Neuralink Timeline

Events

• 2026-04-30 - Capability - Neuralink details surgical robot automation for implant procedure - Neuralink published a video describing its surgical robot work for automating key steps in receiving a Neuralink implant. The company framed the robot as improving safety, reliability, and scalability for implant procedures. The update reinforces the R1… - source: youtube.com
• 2026-04-29 - Capability - Neuralink participant controls robotic arm through CONVOY study - Alex Conley, the second Neuralink participant, used the N1 Implant to control a robotic arm at Barrow Neurological Institute. The robotic arm work is part of Neuralink's CONVOY study, which explores BCI control of assistive devices in real-world use. The… - source: barrowneuro.org
• 2026-01-01 - Market Signal - Neuralink targets high-volume implant production and automated surgical procedures - Neuralink targeted high-volume production of its brain-computer interface devices beginning in 2026. The same report described a planned transition toward fully automated surgical implantation procedures. The update links Neuralink's implant scale-up to… - source: reuters.com
• 2025-06-02 - Funding - Neuralink raises $650 million Series E - ARK Invest, DFJ Growth, Founders Fund, G42, Human Capital, Lightspeed, QIA, Sequoia Capital, Thrive Capital, Valor Equity Partners and Vy Capital participated. Neuralink linked the financing to broader access for people with unmet medical needs and continued… - source: neuralink.com
• 2024-11-24 - Regulatory - Neuralink launches CONVOY feasibility study for robotic arm control - Neuralink received approval and launched CONVOY, a feasibility study extending N1 Implant control to an assistive robotic arm. CONVOY is designed to evaluate whether people with paralysis can use the N1 Implant to control external robotic assistance. The… - source: neuralink.com
• 2024-11-01 - Regulatory - Neuralink receives Health Canada approval for CAN-PRIME Study - Neuralink received Health Canada approval to launch CAN-PRIME, its first international clinical trial. CAN-PRIME extends evaluation of the N1 Implant and R1 Robot system outside the United States. The trial studies safety and early effectiveness of… - source: neuralink.com
• 2024-09-01 - Regulatory - Neuralink receives FDA Breakthrough Device Designation for Blindsight - The visual prosthesis program is intended to restore visual perception for people with severe vision loss. The designation supports faster development and review but does not represent market approval. - source: neuralink.com
• 2024-04-12 - Capability - Neuralink reports PRIME Study progress after first human implant - Neuralink published a progress update on the PRIME Study after the first human implantation. The company said the participant was using the implant to control a computer cursor and digital interfaces. Neuralink also disclosed that some implant threads had… - source: neuralink.com
• 2024-01-29 - Deployment - Neuralink reports first human implant in PRIME Study - Neuralink announced that the first human participant had received its brain-computer interface implant. The PRIME Study evaluates both the wireless implant and the surgical robot used for implantation. The milestone marked Neuralink's first human use of its… - source: reuters.com
• 2023-09-19 - Regulatory - Neuralink opens recruitment for first-in-human PRIME Study - Neuralink opened recruitment for its first-in-human PRIME Study at its first hospital site. The study targets people with quadriplegia due to cervical spinal cord injury or amyotrophic lateral sclerosis. Neuralink described the study as evaluating the… - source: neuralink.com
• 2023-05-01 - Regulatory - Neuralink receives FDA approval to launch first-in-human PRIME Study - Neuralink received FDA approval in May 2023 to launch its first-in-human PRIME Study. The study evaluates the safety and initial effectiveness of the N1 Implant and R1 surgical robot system for people with paralysis. The approval moved Neuralink from… - source: neuralink.com